Decro Pharma Private Limited

Decro Pharma Private Limited - chemicals and materials in Indrad, Gujarat, India. FY 2026 financials and compliance.
CIN U24210GJ2020PTC117562 Incorporated 21 October 2020 ROC Ahmedabad HQ Indrad, Gujarat, India
Active Private Limited Company chemicals and materials
Data last updated
Revenue · FY 2025
₹14.66 Cr
▲ 96.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.5 Cr
Issued & subscribed
Open charges
₹38.8 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Decro Pharma Private Limited

Data last updated: 18 February 2026

Decro Pharma Private Limited is a private limited company based in Indrad, Gujarat, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 21 October 2020, the company has been in operation for over 6 years.

Registered with ROC Ahmedabad under CIN U24210GJ2020PTC117562.

Capital: an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.5 Cr. It is led by directors including Narendra Rajdev Pandey and Bhikan Nimba Patil.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: New Survey No. – 466 Plot No 7 Umiya Industrial Estate Ta. Kadi, Indrad, Gujarat, India – 382715.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.66 Cr, a growth of 96% compared to the previous year.

As per MCA filings, the company has open charges of ₹38.8 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website decropharma.com.

Company Details of Decro Pharma Private Limited
CIN U24210GJ2020PTC117562
Registration Number 117562
Incorporation Date 21 October 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    New Survey No. – 466 Plot No 7 Umiya Industrial Estate Ta. Kadi, Indrad, Gujarat, India – 382715
  • Industry
    Chemicals and Materials, Industrial Chemicals
Company report
Decro Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Decro Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Decro Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Decro Pharma Private Limited

Decro Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Decro Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Decro Pharma Private Limited

Decro Pharma Private Limited is audited by G.C.PATEL & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
G.C.PATEL & CO. Locked Locked Locked
Premium access

Complete auditor history for Decro Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Decro Pharma Private Limited

Decro Pharma Private Limited is governed by 6 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Narendra Rajdev Pandey Director 21 Oct 2020 5 Years 9 Months Current
Bhikan Nimba Patil Director 21 Oct 2020 5 Years 9 Months Current
Hareshbhai Kalabhai Patel Director 21 Oct 2020 5 Years 9 Months Current
Rakesh Ambalal Patel Director 21 Oct 2020 5 Years 9 Months Current
Sangitaben Rakeshkumar Patel Director 08 May 2021 5 Years 2 Months Current
Arvindbhai Patel Director 08 May 2021 5 Years 2 Months Current

Financials of Decro Pharma Private Limited FY 2025 filings available

Decro Pharma Private Limited reported revenue of ₹14.66 Cr (up 96.00% YoY) for FY 2025.

Revenue · FY 2025
₹14.66 Cr ▲ 96.00%
Premium access

Ten-year financial statements for Decro Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Decro Pharma Private Limited

Premium access

Shareholding and ownership data for Decro Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Decro Pharma Private Limited

Open charges
₹38.8 Cr
Satisfied charges
₹0
Breakdown by lending institutions
State Bank of India₹38.80 Cr
Latest charge details
DateLenderAmountStatus
30 Mar 2022 State Bank of India ₹19.4 Cr Open
30 Mar 2022 State Bank of India ₹19.4 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Decro Pharma Private Limited

Decro Pharma Private Limited has a workforce of 0 employees as of Apr 05, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Decro Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Decro Pharma Private Limited

Premium access

GST registrations and filing compliance for Decro Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Decro Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Decro Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Decro Pharma Private Limited

Premium access

MSME payment history for Decro Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Decro Pharma Private Limited

Premium access

Corporate group structure for Decro Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Decro Pharma Private Limited

Premium access

MCA filings and documents for Decro Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Decro Pharma Private Limited

Activity
30 Sep 2025
Decro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Decro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
26 Apr 2024
A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100567876 was modified on 26 Apr 2024.
Charges
26 Apr 2024
A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100568091 was modified on 26 Apr 2024.
Charges
30 Mar 2022
A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100567876 was registered on 30 Mar 2022.
Charges
30 Mar 2022
A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100568091 was registered on 30 Mar 2022.

Frequently Asked Questions about Decro Pharma Private Limited

Decro Pharma Private Limited is an active private limited company in the chemicals and materials sector based in Indrad, Gujarat, India. It was incorporated on 21 October 2020 (6+ years old) and is registered under CIN U24210GJ2020PTC117562.

Decro Pharma Private Limited reported revenue of ₹14.66 Cr for FY 2025 (up 96.00% YoY).

The current directors of Decro Pharma Private Limited are:

The primary industry of Decro Pharma Private Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.

Decro Pharma Private Limited can be reached at the registered office: New Survey No. – 466 Plot No 7 Umiya Industrial Estate Ta. Kadi, Indrad, Gujarat, India – 382715, or through the website decropharma.com.

The authorised capital is ₹6.5 Cr, and the paid-up capital is ₹6.5 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available